In this chapter, Dr. Alexanian provides a snapshot of MD Anderson when he arrived in 1964. He explains that Dr. Bergsagel wanted to combine clinical and basic research and the institution president, R. Lee Clark, MD, wanted to shorten the time between laboratory discoveries and delivery of treatment to patients. Dr. Alexanian lists the programs he inherited on arrival. He tells some history of the Department of Developmental Therapeutics and explains why he joined the Department of Leukemia.https://openworks.mdanderson.org/mchv_interviewchapters/1094/thumbnail.jp
In this chapter, Dr. Alexanian talks about activities of the Research Committee, particularly its pu...
Dr. Tomasovic begins this segment with comments on MD Anderson’s perceived weaknesses in basic resea...
Dr. Freireich explains why the slow evolution of the blood separator made it necessary for him to le...
In this chapter, Dr. Becker notes that when he arrived at MD Anderson, it was a large and complex in...
In this chapter, Dr. Becker discusses the Department of Pathology at MD Anderson when he arrived in ...
The interview begins with Thomas Dunaway Anderson’s recollections of his uncle, Monroe Dunaway Ander...
In this chapter, Dr. Freireich covers several topics, among them changes in MD Anderson\u27s adminis...
In this chapter, Dr. Freireich talks about the Department of Developmental Therapeutics at MD Anders...
In this segment, Dr. Tomasovic talks about coming to MD Anderson in 1980 as an Assistant Professor i...
Dr. Copeland and Dr. Balch [oral history interview] begin this chapter with comments on the fact tha...
Dr. Gehan recollects Dr. R. Lee Clark’s approach to funding, recruitment, and management and the att...
In this chapter, Dr. Becker briefly sketches his career path when he returned to New York and joined...
Dr. Copeland begins this chapter talking about how R. Lee Clark, MD was recruited to be MD Anderson’...
In this chapter, Dr. Benjamin notes that the MD Anderson was intellectually challenging and exciting...
Here Dr. Podoloff tells how he decided to leave private practice in 1985 for a position at MD Anders...
In this chapter, Dr. Alexanian talks about activities of the Research Committee, particularly its pu...
Dr. Tomasovic begins this segment with comments on MD Anderson’s perceived weaknesses in basic resea...
Dr. Freireich explains why the slow evolution of the blood separator made it necessary for him to le...
In this chapter, Dr. Becker notes that when he arrived at MD Anderson, it was a large and complex in...
In this chapter, Dr. Becker discusses the Department of Pathology at MD Anderson when he arrived in ...
The interview begins with Thomas Dunaway Anderson’s recollections of his uncle, Monroe Dunaway Ander...
In this chapter, Dr. Freireich covers several topics, among them changes in MD Anderson\u27s adminis...
In this chapter, Dr. Freireich talks about the Department of Developmental Therapeutics at MD Anders...
In this segment, Dr. Tomasovic talks about coming to MD Anderson in 1980 as an Assistant Professor i...
Dr. Copeland and Dr. Balch [oral history interview] begin this chapter with comments on the fact tha...
Dr. Gehan recollects Dr. R. Lee Clark’s approach to funding, recruitment, and management and the att...
In this chapter, Dr. Becker briefly sketches his career path when he returned to New York and joined...
Dr. Copeland begins this chapter talking about how R. Lee Clark, MD was recruited to be MD Anderson’...
In this chapter, Dr. Benjamin notes that the MD Anderson was intellectually challenging and exciting...
Here Dr. Podoloff tells how he decided to leave private practice in 1985 for a position at MD Anders...
In this chapter, Dr. Alexanian talks about activities of the Research Committee, particularly its pu...
Dr. Tomasovic begins this segment with comments on MD Anderson’s perceived weaknesses in basic resea...
Dr. Freireich explains why the slow evolution of the blood separator made it necessary for him to le...